Raxtozinameran (bnt162b2 mrna covid-19 vaccine) – December 2025

• Brand names:
  • Comirnaty® Omicron XBB.1.5
• Pharmaceutical Company:
  • Pfizer Australia Pty Ltd
• Condition/Indication: New vaccine - Prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2
• Meeting Date: December 2025
• Public Summary Document (PSD) May 2025 - December 2025 PBAC Meetings – (PDF 2.2KB)
• Public Summary Document (PSD) May 2025 - December 2025 PBAC Meetings – (Word 1.9KB)

Related Public Summary Documents

• Raxtozinameran – May 2025